Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

Thomas Urup, Signe Regner Michaelsen, Lars Rønn Olsen, Anders Toft, Ib Jarle Christensen, Kirsten Grunnet, Ole Winther, Helle Broholm, Michael Kosteljanetz, Shohreh Issazadeh-Navikas, Hans Skovgaard Poulsen, Ulrik Lassen

Original languageEnglish
Publication date2016
DOIs
Publication statusPublished - 2016
EventDansk Patologiselskab: Anvendt molekylærpatologi - Scandic Hotel, København
Duration: 10 Mar 201612 Mar 2016

Conference

ConferenceDansk Patologiselskab
LocationScandic Hotel, København
Period10/03/201612/03/2016

Cite this